CoChat

Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria

Cashman, John, Camp, Kathryn, Fakharzadeh, Steven, Fennessey, Paul, Hines, Ronald, Mamer, Orval, Mitchell, Steven, Preti, George, Schlenk, Daniel, Smith, Robert · 2003 · Current Drug Metabolism

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Trimethylaminuria is a rare metabolic disorder that is associated with abnormal amounts of the dietary-derived trimethylamine. Excess unmetabolized trimethylamine in the urine, sweat and other body secretions confers a strong, foul body odor that can affect the individual's ability to work or engage in social activities. This review summarizes the biochemical aspects of the condition and the classification of the disorder into: 1) primary genetic form, 2) acquired form, 3) childhood forms, 4) transient form associated with menstruation, 5) precursor overload and 6) disease states. The genetic variability of the flavin-containing monooxygenase (form 3) that is responsible for detoxication and deodoration of trimethylamine is discussed and put in context with other variant forms of the flavin-containing monooxygenase (forms 1-5). The temporal-selective expression of flavin-containing monooxygenase forms 1 and 3 is discussed in terms of an explanation for childhood trimethylaminuria. Information as to whether variants of the flavin-containing monooxygenase form 3 contributes to hypertension and/or other diseases are presented. Discussion is provided outlining recent bioanalytical approaches to quantify urinary trimethylamine and trimethylamine N-oxide and plasma choline as well as data on self-reporting individuals tested for trimethylaminuria. Finally, trimethylaminuria treatment strategies and nutritional support are described including dietary sources of trimethylamine, vitamin supplementation and drug treatment and issues related to trimethylaminuria in pregnancy and lactation are discussed. The remarkable progress in the biochemical, genetic, clinical basis for understanding the trimethylaminuria condition is summarized and points to needs in the treatment of individuals suffering from trimethylaminuria.

Overview

Integrity signals

Registry

Crossref · 10.2174/1389200033489505

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Cited by

See all 111

Metadata

Authors
Cashman, J., Camp, K., Fakharzadeh, S., Fennessey, P., Hines, R., Mamer, O., Mitchell, S., Preti, G., Schlenk, D., & Smith, R.
Affiliations
Human BioMolecular Research Institute (US)
Venue
Current Drug Metabolism
Published
2003-04-01
Volume
4
Issue
2
Pages
151-170
ISSN
1389-2002 (ISSN-L)
OpenAlex
W2138685029
Cited by
110
References
3
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 12 · 2013: 6 · 2012: 4
FWCI
4.65
Type
journal article
Language
en
Open access
closed
Locations
  • Current Drug Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK 59618, R01DK059618)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords
trimethylaminuria, FMO3, trimethylamine, trimethylamine N-oxide, choline, hypertension, plasma choline, dietary management, vitamin supplementation, pregnancy and lactation, body odor
MeSH terms
Animals, Clinical Trials as Topic, Diet, Genotype, Humans, Hypertension, Liver, Metabolic Diseases, Metabolism, Inborn Errors, Methylamines, Odorants, Oxygenases, Polymorphism, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.